Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients (ReCePI)
Diseases of the Cardiovascular System
What is the purpose of this trial?
The objective of this study is to evaluate the efficacy and safety of RBC transfusion for support of acute anemia in cardiovascular surgery patients based on the clinical outcome of renal impairment following transfusion of red blood cells (RBCs) treated with the INTERCEPT Blood System (IBS) for Red Blood Cells compared to patients transfused with conventional RBCs.
- Ages11 years and older
- Trial withCerus Corporation
- Start Date08/15/2019
- End Date12/31/2022
- Last Updated04/20/2022
- Study HIC#2000024812